“vaccines” Archives

Entry Author Date Location
Gates Foundation Health Chief on Coaxing Pharma to Do Good 11/25/13 National
Sutro Aims to Deliver Anti-Tumor “Warheads” More Precisely 10/01/13 San Francisco
Genocea’s Herpes Vaccine Heads For Critical Proving Ground 09/12/13 Boston
San Diego Life Sciences Roundup: Vical, Fate, Arcturus, and More 08/15/13 San Diego
Theraclone Merges With PharmAthene, Plans to Stay in Seattle 08/01/13 Seattle
Ex-Prometheus Exec Takes the Reins at Dallas’ Gradalis 07/23/13 Texas
Immune Design, NY Non-Profits Team Up to Boost Cancer Drugs 06/12/13 Seattle
Inviragen, Global Health Vaccine Maker, Bought by Takeda for $35M 05/08/13 Boulder/Denver
East Coast Life Sciences Roundup: GSK, Protein Sciences, IMS Health 03/15/13 Boston
Protein Sciences’ Pitch: a “Pure” Flu Vaccine Alternative 03/11/13 New York
Zuckerberg Takes a Small Step in Right Direction, Backing Biotech 02/25/13 National
Harvard i-lab Sprouts Startups: Nucleik, PollVaultr, Vaxess, & More 01/28/13 Boston
Leprosy 2013 – The Problem and the Solutions 01/25/13 Seattle
Oncothyreon Cancer Drug Fails in Final Trial; Shares Tank 12/19/12 Seattle
East Coast Life Sciences Roundup: Selecta, Rib-X, Cambridge, & More 11/30/12 Boston
Seattle Biomed, Emerald Bio and Peers Get Big NIH Contract Extension 11/19/12 Seattle
San Diego Life Sciences Roundup: Optimer, Pfenex, OncoSec, & More 10/19/12 San Diego
Genocea Snags $30M from Gates Foundation, VCs for New Vaccines 10/10/12 Boston
Vaxxas Entices Merck to Try Needle-Free Vaccine Technique 10/08/12 Boston
We Have To Do Better on TB, In King County and High-Burden Countries 09/24/12 Seattle
IDRI, Medicago To Test Self-Injectable Pandemic Flu Vaccine 08/16/12 Seattle
Life Science Innovation NW Notes: SeaGen, NanoString, Viket, & More 07/12/12 Seattle
Gates Foundation’s Jeff Raikes To Start Off Seattle Biotech Event 07/10/12 Seattle
Life Sciences Discovery Fund Gets New Leader, A Familiar Face 07/03/12 Seattle
Building Bridges in a New Global Health Landscape 06/04/12 Seattle
IDRI, Aeras Team Up to Develop Tuberculosis Vaccine 05/09/12 Seattle
Dendreon CEO John Johnson: ‘This is My Last Stop’ 04/17/12 Seattle
Mymetics Ropes in Dendreon, KPCB Vets to Restart Vaccine Developer 04/11/12 San Francisco
Oncothyreon Marches On With ‘Son of Stimuvax’ Cancer Vaccine 04/10/12 Seattle
In Boston Life Sciences News: Akili, Kala, And Genocea 03/16/12 Boston
Page 2 of 9 « previous page · next page »